Human Feedback Types
missingNone explicit
No explicit feedback protocol extracted.
"Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent."
HFEPX · Eval paper review
Azad Singh, Ayantika Das, Amog Rao, Aiman Farooq +6 more
Published
Nov 13, 2026
Citations
0
Trust level
Low
Usefulness score
25/100 (Low)
Extraction confidence
45% (Low)
Derived from extracted protocol signals and abstract evidence.
Rater population
Not reported
Signals refreshed
Nov 13, 2026
This paper is adjacent to HFEPX scope and is best used for background context, not as a primary protocol reference.
Use this as background context only. Do not make protocol decisions from this page alone.
Use this page for context, then validate protocol choices against stronger HFEPX references before implementation decisions.
Best use
Background context only
Use if you need
A secondary eval reference to pair with stronger protocol papers.
What to verify
Validate the evaluation procedure and quality controls in the full paper before operational use.
Main weakness
The available metadata is too thin to trust this as a primary source.
Treat as adjacent context, not a core eval-method reference.
If you are doing eval pipeline work, start here
Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent. However, during the transition from cognitively normal (CN) to mild cognitive impairment (MCI), the disease-related signals are often subtle and confined to only a few brain regions. Existing Joint Embedding Predictive Architecture (JEPA) models learn general structural representations but do not explicitly capture the anatomical regions affected in AD. We propose Anatomically Guided JEPA (AG-JEPA), which introduces anatomical tokens that interact with patch tokens during pretraining to learn region-specific representations from brain regions relevant to neurodegeneration. Building on this representation space, we further propose Prog-AG-JEPA, which models disease progression trajectory as a conditioned latent displacement within this space. We evaluate AG-JEPA across five downstream tasks spanning Alzheimer's disease diagnosis and progression prediction. AG-JEPA improves diagnosis and MCI prognosis, achieving an 8.4 percentage point AUROC gain over the strongest baseline on CN/MCI classification and a 7.1 percentage point gain on out-of-distribution CN/AD classification on the MR-RATE dataset, highlighting its effectiveness across both early-stage detection and cross-cohort generalization. For disease progression modeling, Prog-AG-JEPA consistently outperforms all baselines on future diagnosis and brain volume change prediction, demonstrating the value of anatomically grounded neurodegeneration representations for diagnosis and prognosis.
These are the protocol signals we could actually recover from the available paper metadata. Use them to decide whether this paper is worth deeper reading.
None explicit
No explicit feedback protocol extracted.
"Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent."
Automatic Metrics
Includes extracted eval setup.
"Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent."
Not reported
No explicit QC controls found.
"Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent."
Not extracted
No benchmark anchors detected.
"Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent."
Auroc
Useful for evaluation criteria comparison.
"AG-JEPA improves diagnosis and MCI prognosis, achieving an 8.4 percentage point AUROC gain over the strongest baseline on CN/MCI classification and a 7.1 percentage point gain on out-of-distribution CN/AD classification on the MR-RATE dataset, highlighting its effectiveness across both early-stage detection and cross-cohort generalization."
No benchmark or dataset names were extracted from the available abstract.
Brain MRI can reveal early signs of Alzheimers disease (AD) before measurable cognitive decline becomes apparent.
Based on abstract + metadata only. Check the source paper before making high-confidence protocol decisions.
Human feedback protocol is explicit
No explicit human feedback protocol detected.
Evaluation mode is explicit
Detected: Automatic Metrics
Quality control reporting appears
No calibration/adjudication/IAA control explicitly detected.
Benchmark or dataset anchors are present
No benchmark/dataset anchor extracted from abstract.
Metric reporting is present
Detected: auroc